Alpha Biopharma (2)
Shanghai, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
A clinical-stage biotech focused on targeted oncology therapies, spanning both antibody and small molecule modalities.
Oncology
Technology Platform
Integrated drug discovery platform utilizing high-throughput screening and rational design for both small molecules and antibodies.
Opportunities
Opportunity to demonstrate superior efficacy or safety in a specific cancer subtype, enabling accelerated development or partnership deals.
Risk Factors
Primary risk is clinical, as failure of a lead asset in Phase 2 trials could significantly impact the company's valuation and viability.
Competitive Landscape
Competes in the densely populated field of targeted oncology, requiring exceptional clinical data to stand out among peers and attract partnership interest.